Fourth-quarter device financing reached $4.2bn, up from the previous quarter’s $3.3bn. The initial public offering category made up the most, accounting for $1.3bn, or 32%, of the Q4 total, followed by debt, which brought in an aggregate $1bn, or 25% of the Q4 financing dollars (see Exhibit 1).
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?